Doraiswamy Vinayak (CIK 1862458) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy ATRC (636 shares), Sell ATRC (5,000 shares), Sell ATRC (5,000 shares), Buy ATRC (30,390 shares), Buy ATRC (15,198 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Buy | 636 | $15,124 |
| 2026-05-18 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Sell | 5,000 | $140,650 |
| 2026-03-16 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Sell | 5,000 | $149,150 |
| 2026-03-03 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Buy | 30,390 | $0 |
| 2026-03-03 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Buy | 15,198 | $0 |
| 2026-03-03 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Sell | 15,585 | $487,187 |
| 2025-08-07 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Sell | 2,500 | $91,450 |
| 2025-07-02 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Buy | 822 | $21,240 |
| 2025-05-30 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Sell | 2,500 | $83,600 |
| 2025-03-04 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Buy | 19,359 | $0 |
| 2025-03-04 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Buy | 6,579 | $0 |
| 2025-03-04 | AtriCure, Inc. (ATRC) | Chief Scientific Officer | Sell | 9,672 | $374,693 |
Source: SEC Form 4 filings · as of 2026-07-02